Previous 10 | Next 10 |
The European Commission (EC) approved the expanded use of Bavarian Nordic's ( OTCPK:BVNKF ) ( OTCPK:BVNRY ) smallpox vaccine Imvanex for use in preventing monkeypox and disease caused by vaccinia virus. The Denmark-based company's stock rose +4.73% to DKK349.8 o...
The World Health Organization (WHO) designated the current monkeypox outbreak a public health emergency of international concern (PHEIC) on Saturday. PHEIC designation is WHO's highest level of warning, previously issued for the COVID-19 pandemic and Ebola. The decision follows a ...
A committee of the European Medicines Agency ( EMA ) recommended the expanded approval of Bavarian Nordic's ( OTCPK:BVNKF ) ( OTCPK:BVNRY ) smallpox vaccine Imvanex for use in preventing monkeypox. The Denmark-based company's smallpox vaccine MVA-BN is sold as Jynneo...
GAITHERSBURG, Md., July 18, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, August 1, 2022, at 5:00 pm eastern time to discuss the financial results for the second quarter of 2022, recent business developments, revenue guidance for the ...
Johnson & Johnson ( NYSE: JNJ ) is scheduled to announce Q2 earnings results on Monday, July 18th, before market open. EPS Estimate is $2.55 (+2.8% Y/Y) and the consensus Revenue Estimate is $23.86B (+2.4% Y/Y). has beaten EPS estimates 100% of the time and has bea...
Companies focused on monkeypox vaccines and therapeutics gained in the pre-market Monday after the Danish biotech Bavarian Nordic ( OTCPK:BVNKF ) ( OTCPK:BVNRY ) ( BAVN ) increased its 2022 financial guidance to reflect the recent supply contracts for its monkeypox vaccine, ...
United Kingdom has approved SIGA Technologies's ( NASDAQ: SIGA ) oral tecovirimat for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox in adults and children with a body weight of at least 13kg. Similar formula...
Emergent BioSolutions ( NYSE: EBS ) on Thursday said it had entered into a collaboration agreement with Ridgeback Biotherapeutics for its FDA-approved ebola treatment Ebanga. Ridgeback's Ebanga, a monoclonal antibody, was approved by the U.S. drug regulator in Dec. 202...
GAITHERSBURG, Md. and MIAMI, July 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement with Ridgeback Biotherapeutics (“Ridgeback Bio”), a biotechnology company focused on emerging infectious diseases, intend...
The World Health Organization (WHO) is set to reconvene a meeting of its advisors this month to decide whether the monkeypox constitutes a global health emergency after reporting more than 8,000 cases from 58 countries in the current outbreak. "I continue to be concerned by the scal...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...